用重组凝血因子VIIa治疗凝血因子VII缺乏症。
Treatment of factor VII deficiency with recombinant factor VIIa.
作者信息
Bauer K A
机构信息
Hematology-Oncology Section, Department of Medicine, Brockton-West Roxbury, Harvard Medical School, Boston, Masschusetts, USA.
出版信息
Haemostasis. 1996;26 Suppl 1:155-8. doi: 10.1159/000217259.
PMID:8904192
Abstract
Factor VII deficiency is a relatively infrequent hereditary bleeding disorder. Recombinant factor VIIa has been used to treat patients with factor VII deficiency with bleeding episodes or undergoing surgery. The drug has shown a high efficacy rate and will provide factor VII-deficient patients with a therapeutic agent that is not derived from human plasma.
摘要
凝血因子VII缺乏症是一种相对罕见的遗传性出血性疾病。重组凝血因子VIIa已被用于治疗有出血发作或正在接受手术的凝血因子VII缺乏症患者。该药物已显示出高有效率，并将为凝血因子VII缺乏症患者提供一种非源自人血浆的治疗药物。
Zotero 插件